Do you want to volunteer for Clinical Trials? Register now

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

Register now >

Clinical Trials and Medical Trials is a website that will put you in direct contact with Pharmaceutical Companies, CRO’s (Clinical Research Organisations) and Clinical Investigators that are running Phase I (1) and Phase II (2) clinical trials.

Medical trials are an integral part of the drug development process. Patient and volunteer participation is vital for continued medical research and these trials are carried out under strict regulations.

Register as a Clinical Trial volunteer.

View information about current Clinical Trials.

If at any point you feel that you have changed your mind and are no longer interested in undertaking a medical trial you can unsubscribe from our service. If you are already part way through a medical trial, speak to the Clinical Investigator and they will advise you of your options.

Clinical research companies often offer financial compensation for your time and expenses.

Clinical Trial Information

Register now for clinical trials


FDA nod for CSL’s long-acting haemophilia drug

CSL Behring’s Afstyla has been approved in the US as a long-lasting treatment option for patients with the bleeding disorder haemophilia A. Go to Source

more >

NICE turns down Lilly’s lung cancer drug Portrazza

It is looking unlikely that lung cancer patients in England and Wales will get access to Eli Lilly’s new treatment Portrazza on the National Health Service, after the drug received an initial rejection from cost regulators. Go to Source

more >

June issue of PharmaTimes – out now

Read the June issue of PharmaTimes now – digital and online. Go to Source

more >

NHS England orders national service to handle Soliris

NHS England has announced plans to establish a national service to treat the ultra-rare kidney condition Atypical Haemolytic Uraemic Syndrome (aHUS), and the administration of Alexion’s high-cost Soliris. Go to Source

more >

US OKs first implant for opioid addiction

US regulators have approved the first buprenorphine implant to help treat people addicted to opioids, including prescription painkillers and heroin. Go to Source

more >

Real world study shows ivabradine significantly improved quality of life in elderly patients with heart failure

Older heart failure patients, prescribed Procoralan® (ivabradine), have been shown to experience a significant improvement in quality of life (QoL); a key priority in the treatment of heart… Go to Source

more >